Functional near-infrared spectroscopy as a tool for monitoring treatment-related neurofunctional changes in posttraumatic stress disorder and trauma-related symptomatology: a narrative review.
5 affiliations
- 1International research center for Cognitive Applied Neuroscience (IrcCAN), Catholic University of the Sacred Heart, Milan, Italy.
- 2Research Unit in Affective and Social Neuroscience, Department of Psychology, Catholic University of the Sacred Heart, Milan, Italy.
- 3Neuropsychology Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni, 4, Brescia, 25125, Italy.
- 4Neuropsychology Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Via Pilastroni, 4, Brescia, 25125, Italy. [email protected].
- 5School of Psychology, University of Roehampton, London, UK.
Abstract
Background
Posttraumatic stress disorder (PTSD) is characterized by substantial heterogeneity in symptom presentation, illness trajectory, and treatment response, highlighting the need for objective approaches capable of monitoring treatment-related neurofunctional changes beyond conventional symptom-based outcomes. Functional near-infrared spectroscopy (fNIRS) is an increasingly used non-invasive neuroimaging technique that enables repeated assessment of cortical hemodynamics in clinically feasible settings. Although fNIRS has been widely applied to characterize neurofunctional alterations associated with PTSD, its potential role in monitoring longitudinal treatment-related brain changes has not been critically synthesized.Methods
A narrative review was conducted using a structured search strategy across PubMed, Web of Science, Scopus, PsycINFO, and the Cochrane Library to identify studies published up to 30 January 2026. Studies were eligible if they included adults with PTSD or clinically significant trauma-related symptomatology and employed repeated NIRS/fNIRS assessments to evaluate neurofunctional changes associated with pharmacological or non-pharmacological therapeutic interventions.Results
Four studies met the eligibility criteria and were included in the qualitative synthesis. Across the included studies, the non-pharmacological interventions consisted of trauma-focused psychotherapy, attention-based cognitive training, and equine-assisted services. No eligible longitudinal studies evaluating pharmacological treatments using repeated NIRS/fNIRS assessments were identified. Across studies, treatment was consistently associated with modulation of prefrontal cortical hemodynamic activity, although the direction and magnitude of neurofunctional changes varied according to intervention type, experimental paradigm, and methodological approach. Overall, the available evidence supports the feasibility of repeated fNIRS assessment while highlighting substantial methodological heterogeneity and the limited maturity of the current evidence base.Conclusions
Current evidence suggests that fNIRS represents a promising and clinically feasible approach for monitoring treatment-related neurofunctional changes in PTSD and trauma-related symptomatology, particularly during non-pharmacological interventions targeting prefrontal regulatory processes. Rather than replacing established neuroimaging techniques such as functional magnetic resonance imaging, fNIRS should be considered a complementary tool that is particularly suitable for repeated assessments in real-world clinical settings. Future research should prioritize adequately powered longitudinal studies, standardized acquisition and analytical protocols, multimodal neuroimaging approaches, and the inclusion of pharmacological treatment trials to determine the potential of fNIRS as a candidate longitudinal neurofunctional biomarker of treatment response.Clinical trial number
Not applicable.
Related
- Real-World Evaluation of a Near-Infrared Spectroscopy–based Noninvasive Glucose Monitoring Device in Adults With Type 2 Diabetes
- Rapid estimation of photon measurement density functions using a deep convolutional neural network for functional near-infrared spectroscopy
- Spatiotemporal feature-based investigation of major depressive disorder and emotion recognition using functional near infrared spectroscopy.
- Phenotypic structure and genetic correlates of adolescent psychiatric symptomatology in versus out of autism
- Chrononutrition and Prenatal Mental Health: The Relationship Between Food Intake Indicators and Prenatal Depressive Symptomatology
BibTeX
@article{balconi2026functional,
title = {{Functional near-infrared spectroscopy as a tool for monitoring treatment-related neurofunctional changes in posttraumatic stress disorder and trauma-related symptomatology: a narrative review.}},
author = {Michela Balconi and Elena Gobbi and Ilaria Pagnoni and Elena Campana and Marco Sandrini and Rosa Manenti and Maria Cotelli},
journal = {BMC psychiatry},
year = {2026},
month = jul,
doi = {10.1186/s12888-026-08430-1},
url = {https://europepmc.org/article/MED/42897537},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Functional near-infrared spectroscopy as a tool for monitoring treatment-related neurofunctional changes in posttraumatic stress disorder and trauma-related symptomatology: a narrative review.
AU - Michela Balconi
AU - Elena Gobbi
AU - Ilaria Pagnoni
AU - Elena Campana
AU - Marco Sandrini
AU - Rosa Manenti
AU - Maria Cotelli
PY - 2026
DA - 2026/07/01
JO - BMC psychiatry
DO - 10.1186/s12888-026-08430-1
UR - https://europepmc.org/article/MED/42897537
AB - Background Posttraumatic stress disorder (PTSD) is characterized by substantial heterogeneity in symptom presentation, illness trajectory, and treatment response, highlighting the need for objective approaches capable of monitoring treatment-related neurofunctional changes beyond conventional symptom-based outcomes. Functional near-infrared spectroscopy (fNIRS) is an increasingly used non-invasive neuroimaging technique that enables repeated assessment of cortical hemodynamics in clinically feasible settings. Although fNIRS has been widely applied to characterize neurofunctional alterations associated with PTSD, its potential role in monitoring longitudinal treatment-related brain changes has not been critically synthesized.Methods A narrative review was conducted using a structured search strategy across PubMed, Web of Science, Scopus, PsycINFO, and the Cochrane Library to identify studies published up to 30 January 2026. Studies were eligible if they included adults with PTSD or clinically significant trauma-related symptomatology and employed repeated NIRS/fNIRS assessments to evaluate neurofunctional changes associated with pharmacological or non-pharmacological therapeutic interventions.Results Four studies met the eligibility criteria and were included in the qualitative synthesis. Across the included studies, the non-pharmacological interventions consisted of trauma-focused psychotherapy, attention-based cognitive training, and equine-assisted services. No eligible longitudinal studies evaluating pharmacological treatments using repeated NIRS/fNIRS assessments were identified. Across studies, treatment was consistently associated with modulation of prefrontal cortical hemodynamic activity, although the direction and magnitude of neurofunctional changes varied according to intervention type, experimental paradigm, and methodological approach. Overall, the available evidence supports the feasibility of repeated fNIRS assessment while highlighting substantial methodological heterogeneity and the limited maturity of the current evidence base.Conclusions Current evidence suggests that fNIRS represents a promising and clinically feasible approach for monitoring treatment-related neurofunctional changes in PTSD and trauma-related symptomatology, particularly during non-pharmacological interventions targeting prefrontal regulatory processes. Rather than replacing established neuroimaging techniques such as functional magnetic resonance imaging, fNIRS should be considered a complementary tool that is particularly suitable for repeated assessments in real-world clinical settings. Future research should prioritize adequately powered longitudinal studies, standardized acquisition and analytical protocols, multimodal neuroimaging approaches, and the inclusion of pharmacological treatment trials to determine the potential of fNIRS as a candidate longitudinal neurofunctional biomarker of treatment response.Clinical trial number Not applicable.
SN - 1471-244X
ER -